Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Overviews: 9 Aspects of this Diagnoses
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Possible Special Education
      • Possible Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • First Pages of Diagnoses from the Diagnostic and Statistical Manual and the Codes from the ICD-10 for Diagnosis and Compensation
  • Medical & Educational Downloads
  • Contact Us
Select Page

Mother-Father Distress, Accommodation, and Child Eating Disorder Behaviors: A Dyadic Perspective

by jlohrconsulting | Sep 5, 2025 | Uncategorized

Fam Process. 2025 Sep;64(3):e70070. doi: 10.1111/famp.70070. ABSTRACT Parental psychological distress and accommodating and enabling behaviors may represent maintaining factors of anorexia nervosa (AN). However, very few studies included both parents; their...

Exploratory study on the potential benefits of prophylactic levetiracetam after acute spontaneous intracerebral hemorrhage

by jlohrconsulting | Sep 5, 2025 | Uncategorized

Front Neurol. 2025 Aug 20;16:1580539. doi: 10.3389/fneur.2025.1580539. eCollection 2025. ABSTRACT IMPORTANCE: Current guidelines recommend against the routine use of seizure prophylaxis in acute spontaneous intracerebral hemorrhage (sICH). OBJECTIVE: The goal of this...

Ischemic stroke of undetermined source as a priming event for brain metastasis: a case report and systematic literature review

by jlohrconsulting | Sep 5, 2025 | Uncategorized

Front Oncol. 2025 Aug 20;15:1638420. doi: 10.3389/fonc.2025.1638420. eCollection 2025. ABSTRACT The association between ischemic stroke (IS) and malignancy is well established. Cancer-related strokes are predominantly embolic and classified as embolic strokes of...

Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)

by jlohrconsulting | Sep 5, 2025 | Uncategorized

Front Pharmacol. 2025 Aug 20;16:1623921. doi: 10.3389/fphar.2025.1623921. eCollection 2025. ABSTRACT OBJECTIVE: Laronidase is the first drug of enzyme replacement therapy approved for the treatment of mucopolysaccharidosis type I (MPS I). However, its adverse events...

Association between anhedonia and ventral striatum-MPFC connectivity in first-episode, treatment-naive major depressive disorder

by jlohrconsulting | Sep 5, 2025 | Uncategorized

J Affect Disord. 2025 Sep 2:120214. doi: 10.1016/j.jad.2025.120214. Online ahead of print. ABSTRACT BACKGROUND: Evidence demonstrated that frontostriatal disruption may result in anhedonia in major depressive disorder (MDD). However, limited research examined the...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments